Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

669 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
Linke A, Chandrasekhar J, Sartori S, Lefevre T, van Belle E, Schaefer U, Tchetche D, Sardella G, Webb J, Colombo A, Windecker S, Vogel B, Farhan S, Sorrentino S, Sharma M, Snyder C, Asgar A, Dumonteil N, Tamburino C, Hink U, Violini R, Stella P, Bernstein D, Deliargyris E, Hengstenberg C, Baber U, Mehran R, Anthopoulos P, Dangas G; BRAVO-3 Investigators. Linke A, et al. Among authors: lefevre t. Catheter Cardiovasc Interv. 2017 Nov 15;90(6):1016-1026. doi: 10.1002/ccd.27154. Epub 2017 Jul 19. Catheter Cardiovasc Interv. 2017. PMID: 28498562 Clinical Trial.
Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial.
Chevalier B, Lancelin B, Koning R, Henry M, Gommeaux A, Pilliere R, Elbaz M, Lefevre T, Boughalem K, Marco J, Dupouy P; HEMOSTASE Trial Investigators. Chevalier B, et al. Among authors: lefevre t. Catheter Cardiovasc Interv. 2003 Mar;58(3):285-91. doi: 10.1002/ccd.10431. Catheter Cardiovasc Interv. 2003. PMID: 12594688 Clinical Trial.
Classification of coronary artery bifurcation lesions and treatments: time for a consensus!
Louvard Y, Thomas M, Dzavik V, Hildick-Smith D, Galassi AR, Pan M, Burzotta F, Zelizko M, Dudek D, Ludman P, Sheiban I, Lassen JF, Darremont O, Kastrati A, Ludwig J, Iakovou I, Brunel P, Lansky A, Meerkin D, Legrand V, Medina A, Lefèvre T. Louvard Y, et al. Among authors: lefevre t. Catheter Cardiovasc Interv. 2008 Feb 1;71(2):175-83. doi: 10.1002/ccd.21314. Catheter Cardiovasc Interv. 2008. PMID: 17985377 Free article.
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II).
Routledge HC, Lefèvre T, Colombo A, Oldroyd KG, Hamm CW, Guagliumi G, von Scheidt W, Guetta V, Ruzyllo W, Wittebols K, Goedhart DM, Serruys PW. Routledge HC, et al. Among authors: lefevre t. EuroIntervention. 2009 Jun;5(2):190-6. doi: 10.4244/eijv5i2a30. EuroIntervention. 2009. PMID: 20449929 Clinical Trial.
669 results